The effect of probiotic bacteria on faecal microbiota composition and metabolite production using in vitro batch cultures.

Appetite ◽  
2021 ◽  
pp. 105545
Author(s):  
Jessica Eastwood ◽  
Claire Williams ◽  
Daniel Lamport ◽  
Gemma Walton
2014 ◽  
Vol 112 (8) ◽  
pp. 1303-1314 ◽  
Author(s):  
Shahrul R. Sarbini ◽  
Sofia Kolida ◽  
Eddie R. Deaville ◽  
Glenn R. Gibson ◽  
Robert A. Rastall

The energy-salvaging capacity of the gut microbiota from dietary ingredients has been proposed as a contributing factor for the development of obesity. This knowledge generated interest in the use of non-digestible dietary ingredients such as prebiotics to manipulate host energy homeostasis. In the present study, thein vitroresponse of obese human faecal microbiota to novel oligosaccharides was investigated. Dextrans of various molecular weights and degrees of branching were fermented with the faecal microbiota of healthy obese adults in pH-controlled batch cultures. Changes in bacterial populations were monitored using fluorescentin situhybridisation and SCFA concentrations were analysed by HPLC. The rate of gas production and total volume of gas produced were also determined. In general, the novel dextrans and inulin increased the counts of bifidobacteria. Some of the dextrans were able to alter the composition of the obese human microbiota by increasing the counts ofBacteroides–Prevotellaand decreasing those ofFaecalibacterium prausnitziiandRuminococcus bromii/R. flavefaciens. Considerable increases in SCFA concentrations were observed in response to all substrates. Gas production rates were similar during the fermentation of all dextrans, but significantly lower than those during the fermentation of inulin. Lower total gas production and shorter time to attain maximal gas production were observed during the fermentation of the linear 1 kDa dextran than during the fermentation of the other dextrans. The efficacy of bifidobacteria to ferment dextrans relied on the molecular weight and not on the degree of branching. In conclusion, there are no differences in the profiles between the obese and lean human faecal fermentations of dextrans.


2016 ◽  
Vol 116 (6) ◽  
pp. 1116-1124 ◽  
Author(s):  
E. Pérez-López ◽  
D. Cela ◽  
A. Costabile ◽  
I. Mateos-Aparicio ◽  
P. Rupérez

AbstractAt present, there is a huge interest in finding new prebiotics from agrofood industrial waste, such as the soyabean by-product Okara, rich in insoluble dietary fibre. A previous treatment of Okara with high hydrostatic pressure assisted by the food-grade enzymeUltraflo®L achieved a 58·2 % increment in its soluble dietary fibre (SDF) contents. Therefore, potential prebiotic effect of both treated and native Okara was assayed using 48 h, pH-controlled, anaerobic batch cultures inoculated with human faecal slurries, which simulate the human gut. Changes in faecal microbiota were evaluated using 16S rRNA-based fluorescencein situhybridisation, whereas release of SCFA and lactic acid was assessed by HPLC. Both Okara samples exhibited potential prebiotic effects but Okara treated to maximise its SDF content showed higher SCFA plus lactic acid, better growth promotion of beneficial bacteria, including bifidobacteria after 4 and 48 h and lactobacilli after 4 h of fermentation, and a greater inhibition of potentially harmful bacterial groups such as clostridia and Bacteroides. Differences found between fructo-oligosaccharides and Okara substrates could be attributed to the great complexity of Okara’s cell wall, which would need longer times to be fermented than other easily digested molecules, thus allowing an extended potential prebiotic effect. These results support anin vitropotential prebiotic effect of Okara.


2016 ◽  
Vol 7 (3) ◽  
pp. 1501-1507 ◽  
Author(s):  
Bin Xue ◽  
Jinli Xie ◽  
Jiachen Huang ◽  
Long Chen ◽  
Lijuan Gao ◽  
...  

This study investigated the effect of plant polyphenols on faecal microbiota metabolizing oligosaccharides. The results show that plant polyphenols can change the pathway of degrading FOS or even energy metabolism in vivo by altering gut microbiota composition.


2017 ◽  
Vol 84 (2) ◽  
Author(s):  
Silvia W. Gratz ◽  
Valerie Currie ◽  
Anthony J. Richardson ◽  
Gary Duncan ◽  
Grietje Holtrop ◽  
...  

ABSTRACT Mycotoxin contamination of cereal grains causes well-recognized toxicities in animals and humans, but the fate of plant-bound masked mycotoxins in the gut is less well understood. Masked mycotoxins have been found to be stable under conditions prevailing in the small intestine but are rapidly hydrolyzed by fecal microbiota. This study aims to assess the hydrolysis of the masked mycotoxin deoxynivalenol-3-glucoside (DON3Glc) by the microbiota of different regions of the porcine intestinal tract. Intestinal digesta samples were collected from the jejunum, ileum, cecum, colon, and feces of 5 pigs and immediately frozen under anaerobic conditions. Sample slurries were prepared in M2 culture medium, spiked with DON3Glc or free deoxynivalenol (DON; 2 nmol/ml), and incubated anaerobically for up to 72 h. Mycotoxin concentrations were determined using liquid chromatography-tandem mass spectrometry, and the microbiota composition was determined using a quantitative PCR methodology. The jejunal microbiota hydrolyzed DON3Glc very slowly, while samples from the ileum, cecum, colon, and feces rapidly and efficiently hydrolyzed DON3Glc. No further metabolism of DON was observed in any sample. The microbial load and microbiota composition in the ileum were significantly different from those in the distal intestinal regions, whereas those in the cecum, colon and feces did not differ. IMPORTANCE Results from this study clearly demonstrate that the masked mycotoxin DON3Glc is hydrolyzed efficiently in the distal small intestine and large intestine of pigs. Once DON is released, toxicity and absorption in the distal intestinal tract likely occur in vivo. This study further supports the need to include masked metabolites in mycotoxin risk assessments and regulatory actions for feed and food.


2008 ◽  
Vol 66 (3) ◽  
pp. 516-527 ◽  
Author(s):  
Delphine M.A. Saulnier ◽  
Glenn R. Gibson ◽  
Sofia Kolida

2020 ◽  
Vol 4 (Supplement_2) ◽  
pp. 1578-1578
Author(s):  
Giulio Pasinetti

Abstract Objectives Synbiotics, the combination of probiotics and prebiotics, can be designed to produce specific bioavailable metabolites that penetrate the blood-brain-barrier and reduce neuropathologies associated with Alzheimer's Disease (AD). We designed an in vitro model of the human gastrointestinal tract that can be used to optimize the production of metabolites from synbiotic formulations using machine learning algorithms that can then be tested in animal models of AD. Our objective is to optimize/characterize a synbiotic's metabolite production using an in vitro bioreactor as a therapeutic tool against AD. We hypothesize that a synbiotic designed towards the production of specific brain-bioactive metabolites will synergistically mitigate the neuro- and systemic-pathologies associated with AD. Methods Using the in vitro model of the human gastrointestinal tract, we have used this optimized combination of polyphenols and tested 15 combinations of 6 probiotic bacteria as a synbiotic to optimize metabolite production using a multivariate regression algorithm (MARS) and found that three probiotic bacteria, Lactobacillus plantarum, Bifidobacterium infantis and L. salivarius together synergistically improve the production of brain bioavailable metabolites including quercetin, kamferin, 4-hydroxyphenylpyruvic acid and 4-hydroxyphenylacetic acid. Results We have found that two polyphenolic metabolites 3-hydroxybenzoic acid and 3-(3’-hydroxyphenyl) propionic acid derived from a grapeseed polyphenolic extract (GSPE) can penetrate the blood-brain-barrier and in vitro, inhibit the aggregation of amyloid plaques and tau fibrils. Increasing the diversity of the polyphenolic pool by adding a concord grape extract and resveratrol to the GSPE, we provided greater protection against cognitive impairment and amyloid aggregation in an AD mouse model than the components alone. Conclusions In vitro studies have confirmed that these metabolites have potent anti-inflammatory activity. This synbiotic combining potent grape-derived polyphenolic precursors with bioactive probiotic bacteria has the potential to slow the progression and treat AD by synergistically targeting multiple of its neuropathologies including inflammation, amyloid aggregation and tau fibril formation. Funding Sources These studies were funded by the NCCIH P50 AT008661 Center.


2016 ◽  
Vol 94 (suppl_5) ◽  
pp. 225-225
Author(s):  
C. L. Rosser ◽  
L. Jin ◽  
K. A. Beauchemin ◽  
M. Oba ◽  
S. M. Cutting ◽  
...  
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document